Perceptive Advisors - FORWARD PHARMA A/S ownership

Quarter-by-quarter ownership
Perceptive Advisors ownership history of FORWARD PHARMA A/S
ValueSharesWeighting
Q2 2017$3,959,000
-48.1%
194,718
-45.0%
0.20%
-54.3%
Q1 2017$7,634,000
+29.0%
354,241
-10.1%
0.44%
+3.3%
Q4 2016$5,918,000
-30.3%
394,241
-2.5%
0.42%
-23.2%
Q3 2016$8,494,000
+50.1%
404,472
+29.9%
0.55%
+39.8%
Q2 2016$5,658,000
+78.7%
311,400
+67.1%
0.39%
+41.0%
Q1 2016$3,167,000186,3000.28%
Other shareholders
FORWARD PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 1,387,853$28,215,0004.38%
SENZAR ASSET MANAGEMENT, LLC 652,500$13,265,0003.27%
Baupost Group 6,364,059$129,381,0001.48%
Assured Investment Management LLC 1,511,043$26,982,0000.56%
Perceptive Advisors 194,718$3,959,0000.20%
Rhenman & Partners Asset Management AB 36,584$744,0000.11%
DRW Securities, LLC 17,000$346,0000.06%
NJ State Employees Deferred Compensation Plan 15,000$305,0000.06%
Freedom Investment Management, Inc. 20,178$410,0000.02%
Acrospire Investment Management LLC 942$19,0000.02%
View complete list of FORWARD PHARMA A/S shareholders